Initial evidence of the existence of hemangioblasts in mammalian cells comes from studies using the in vitro embryonic stem (ES) cell differentiation system. 20–22 Vascular endothelial growth factor ...

Objective To examine healthcare resource utilisation (HRU) and direct medical costs for patients with diabetic macular oedema (DME) treated with antivascular endothelial growth factor (anti-VEGF) in ...

A proportional relationship between the magnitude of dilation and endothelial function has been suggested. 22 Impaired FMD is one of the early, reversible manifestations of vascular disease, and may ...

Objective To determine the effects of the intraocular injection of antivascular endothelial growth factor (anti-VEGF) drugs on the refractive status of infants with retinopathy of prematurity (ROP).

Cyclic peptide antagonist c[YYDEGLEE]-NH2, which disrupts the interaction between vascular endothelial growth factor (VEGF) and its receptors (VEGFRs), represents a promising tool in the fight against ...

In line with this hypothesis, PTX3 was upregulated in hyperproliferative dermal lymphatic vessels in response to constitutive activation of PI3 (phosphoinositide 3) kinase-signaling. 66 Such PTX3 high ...

Background Pseudoexfoliation syndrome (PXF) is an idiopathic, elastogenesis-associated systemic disease characterised by amyloid-like material aggregates in the eye. Elevated plasma and aqueous humour ...

In endothelial cells treated with participants’ sera, vascular endothelial growth factor-stimulated nitric oxide levels were significantly lower for the marijuana smoker vs the nonuser group ...